Cargando…
Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High-Risk for Psychosis
BACKGROUND: Animal models indicate GABAergic dysfunction in the development of psychosis, and that benzodiazepine (BDZ) exposure can prevent the emergence of psychosis-relevant phenotypes. However, whether BDZ exposure influences the risk of psychosis in humans is unknown. METHODS: This observationa...
Autores principales: | Livingston, Nicholas R., De Micheli, Andrea, McCutcheon, Robert, Butler, Emma, Hamdan, Marwa, Grace, Anthony A., McGuire, Philip, Egerton, Alice, Fusar-Poli, Paolo, Modinos, Gemma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462200/ https://www.ncbi.nlm.nih.gov/pubmed/37645948 http://dx.doi.org/10.1101/2023.08.15.23294108 |
Ejemplares similares
-
Hippocampal circuit dysfunction in psychosis
por: Knight, Samuel, et al.
Publicado: (2022) -
Correction: Hippocampal circuit dysfunction in psychosis
por: Knight, Samuel, et al.
Publicado: (2022) -
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
por: Oliver, Dominic, et al.
Publicado: (2023) -
Real-world long-term outcomes in individuals at clinical risk for
psychosis: The case for extending duration of care
por: Fusar-Poli, Paolo, et al.
Publicado: (2020) -
Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis
por: Catalan, Ana, et al.
Publicado: (2022)